Cost-effectiveness analysis of sacral neuromodulation and botulinum toxin A treatment for patients with idiopathic overactive bladder

Randall K. Leong, Stephan G. G. de Wachter*, Manuela A. Joore, Philip E. V. A. Van Kerrebroeck

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)558-564
JournalBJU International
Issue number4
Publication statusPublished - Aug 2011


  • sacral neuromodulation
  • botulinum toxin
  • cost-effectiveness

Cite this